This book provides an exciting introduction to organic chemistry for students majoring in chemistry and in related disciplines, especially the health and biological sciences. In this Fourth Edition, Brown, Foote, and Iverson build on the text's highly-praised hallmarks of unifying mechanistic themes, focusing on problem-solving, using applied problems from the pharmaceutical field, and making innovative use of color and emphasis on visualization. The new edition features increased coverage of mechanisms, more examples of bio-organic chemistry especially relevant to pre-medical students, new in-text learning aids including "How To" boxes, and state-of-the-art text/media integration with the Organic ChemistryNow Website.
William H. Brown is Emeritus Professor of Chemistry at Beloit College, where he has twice been named Teacher of the Year. His teaching responsibilities include organic chemistry, advanced organic chemistry, and, more recently, special topics in pharmacology and drug synthesis. He received his Ph.D. from Columbia University under the direction of Gilbert Stork and did postdoctoral work at California Institute of Technology and the University of Arizona.
Christopher S. Foote received his B.S. in 1957 from Yale University and his Ph.D. in 1962 from Harvard University. His scholarly credits include Sloan Fellow 1965-1967; Guggenheim Fellow 1967-1968; ACS Baekland Award, 1975; ACS Cope Scholar, 1994; Southern California Section ACS Tolman Medal, 1996; President, American Society for Photobiology, 1988-1989; and Senior Editor, ACCOUNTS OF CHEMICAL RESEARCH. He was Professor of Chemistry at UCLA.
Brent L. Iverson received his Ph.D. from Stanford University in 1982 and currently teaches at University of Texas, Austin. He is a distinguished teacher and respected researcher. Iverson's research group has developed methods for recombinant antibody or enzyme cloning and has directed its evolution. In collaboration with the Georgiou group, he pioneered a novel E. coli surface expression/FACS selection technology that has allowed the group to enhance antibody affinity.